Pharmagest Interactive SA
F:PHF

Watchlist Manager
Pharmagest Interactive SA Logo
Pharmagest Interactive SA
F:PHF
Watchlist
Price: 49.45 EUR -1.3%
Market Cap: 743.4m EUR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one PHF stock under the Base Case scenario is 60.51 EUR. Compared to the current market price of 49.45 EUR, Pharmagest Interactive SA is Undervalued by 18%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PHF Relative Value
Base Case
60.51 EUR
Undervaluation 18%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.4
P/S
P/S
Price to Sales
3.4
vs History
84
vs Industry
42
Median 3Y
3.7
Median 5Y
5.4
Industry
2.4
Forward
3.1
More Details
20.5
P/E
P/E
Price to Earnings
20.5
vs History
66
vs Industry
37
Median 3Y
20.1
Median 5Y
25.1
Industry
22.5
Forward
16.8
More Details
15.6
P/OCF
P/OCF
Price to OCF
15.6
vs History
69
vs Industry
34
Median 3Y
15.7
Median 5Y
19.6
Industry
14.4
More Details
35.6
P/FCFE
P/FCFE
Price to FCFE
35.6
vs History
33
vs Industry
22
Median 3Y
25.4
Median 5Y
29.4
Industry
20.4
More Details
3.2
P/B
P/B
Price to Book Value
3.2
vs History
87
vs Industry
35
Median 3Y
4
Median 5Y
6.1
Industry
2.2
More Details
3.3
EV/S
EV/S
Enterprise Value to Sales
3.3
vs History
82
vs Industry
44
Median 3Y
3.6
Median 5Y
5.3
Industry
2.6
Forward
3
More Details
4.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.9
vs History
82
vs Industry
55
Median 3Y
5.2
Median 5Y
7.8
Industry
5.2
More Details
12.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.4
vs History
71
vs Industry
39
Median 3Y
12.9
Median 5Y
16.5
Industry
11.9
Forward
10.2
More Details
16.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
16.5
vs History
66
vs Industry
38
Median 3Y
16.5
Median 5Y
20.6
Industry
16.3
Forward
13
More Details
15.2
EV/OCF
EV/OCF
Enterprise Value to OCF
15.2
vs History
71
vs Industry
36
Median 3Y
15.4
Median 5Y
19.2
Industry
14.5
More Details
20.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
20.2
vs History
76
vs Industry
27
Median 3Y
21.5
Median 5Y
24.5
Industry
17.9
More Details
2.1
EV/IC
EV/IC
Enterprise Value to IC
2.1
vs History
84
vs Industry
46
Median 3Y
2.6
Median 5Y
4.2
Industry
1.9
More Details

Multiples Across Competitors

PHF Competitors Multiples
Pharmagest Interactive SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Pharmagest Interactive SA
F:PHF
743.3m EUR 3.4 20.5 12.4 16.5
US
Veeva Systems Inc
NYSE:VEEV
44.9B USD 15.7 57.5 47.9 50.4
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
31.3B AUD 164 318.4 222.7 222.7
US
Doximity Inc
NYSE:DOCS
11.7B USD 20.5 52.3 44.7 46.8
JP
M3 Inc
TSE:2413
1.5T JPY 5.3 37.5 21.2 25.5
SE
Sectra AB
STO:SECT B
67B SEK 32.4 118.9 -146.7 -146.7
US
Waystar Holding Corp
NASDAQ:WAY
6B USD 6 70.1 18.4 32.8
CN
Winning Health Technology Group Co Ltd
SZSE:300253
22.7B CNY 8.6 296.8 101.9 101.9
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
259.2B INR 0 0 0 0
US
Vocera Communications Inc
F:V00
2.4B EUR 12 -329.9 269.4 4 313.8
P/E Multiple
Earnings Growth PEG
FR
Pharmagest Interactive SA
F:PHF
Average P/E: 113.9
20.5
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
57.5
32%
1.8
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
318.4
38%
8.4
US
Doximity Inc
NYSE:DOCS
52.3
16%
3.3
JP
M3 Inc
TSE:2413
37.5
N/A N/A
SE
Sectra AB
STO:SECT B
118.9
16%
7.4
US
W
Waystar Holding Corp
NASDAQ:WAY
70.1
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
296.8
N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -329.9 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Pharmagest Interactive SA
F:PHF
Average EV/EBITDA: 84.5
12.4
12%
1
US
Veeva Systems Inc
NYSE:VEEV
47.9
38%
1.3
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
222.7
38%
5.9
US
Doximity Inc
NYSE:DOCS
44.7
21%
2.1
JP
M3 Inc
TSE:2413
21.2
13%
1.6
SE
Sectra AB
STO:SECT B
Negative Multiple: -146.7 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
18.4
19%
1
CN
Winning Health Technology Group Co Ltd
SZSE:300253
101.9
48%
2.1
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
US
V
Vocera Communications Inc
F:V00
269.4
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Pharmagest Interactive SA
F:PHF
Average EV/EBIT: 539.3
16.5
14%
1.2
US
Veeva Systems Inc
NYSE:VEEV
50.4
39%
1.3
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
222.7
36%
6.2
US
Doximity Inc
NYSE:DOCS
46.8
22%
2.1
JP
M3 Inc
TSE:2413
25.5
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -146.7 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
32.8
49%
0.7
CN
Winning Health Technology Group Co Ltd
SZSE:300253
101.9
47%
2.2
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
US
V
Vocera Communications Inc
F:V00
4 313.8
N/A N/A

See Also

Summary
PHF intrinsic value, competitors valuation, and company profile.
DCF Valuation
PHF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PHF stock valuation using valuation multiples.
Wall Street Estimates
PHF price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PHF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 274,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.